Cancer: How Worthwhile is Non-Curative Treatment?

  • Maurice L. Slevin
  • Teresa Tate

Part of the Focus on Cancer book series (3292)

Table of contents

  1. Front Matter
    Pages i-xvii
  2. Non-Curative Surgery

    1. Front Matter
      Pages 1-1
    2. Jonathan D. Harrison, John W. L. Fielding
      Pages 3-24
    3. S. J. Watson, R. J. Nicholls
      Pages 25-54
    4. John H. Shepherd, Robin Crawford
      Pages 55-63
    5. D. G. Porter, D. G. T. Thomas
      Pages 71-82
    6. Ugo Pastorino, Peter Goldstraw
      Pages 83-101
  3. Non-Curative Radiotherapy

    1. Front Matter
      Pages 103-103
    2. D. J. Boote, N. M. Bleehen
      Pages 105-111
    3. M. E. B. Powell, P. J. Hoskin
      Pages 113-127
    4. D. J. Sebag-Montefiore, S. J. Arnott
      Pages 129-139
    5. D. J. Sebag-Montefiore, S. J. Arnott
      Pages 141-146
    6. R. Barton, L. Brazil, Michael Brada
      Pages 159-172
    7. Gillian M. Sadler, Jeffrey S. Tobias
      Pages 173-185
  4. Non-Curative Chemotherapy

    1. Front Matter
      Pages 187-187
    2. C. M. McLean, R. C. F. Leonard
      Pages 199-214
    3. G. Middleton, D. Cunningham
      Pages 231-243
    4. G. Middleton, D. Cunningham
      Pages 245-258
    5. J. A. Prendiville, M. E. Gore
      Pages 259-283
    6. F. Anthony Greco, John D. Hainsworth
      Pages 285-303
  5. Back Matter
    Pages 304-310

About this book


Cancer is a major issue in the provision of health care. It is estimated that one in four people in developed countries are likely to develop it at some time. As longevity steadily increases, the incidence of malignant disease is expected to rise further. Important advances in the control of cancer have taken place and curative treatment has improved, notably in some of the rarer tumours, particularly in children. Advances in the more common cancers have been less marked, although adjunctive systemic treatment and population screening are lowering mortality from the most prevalent cance- carcinoma of the breast. Despite this progress, complete control of malignant disease is still a long way off. However, our understanding of the molecular biology of cancer has increased enormously in recent years and the application of this knowledge holds considerable promise for developing new therapeutic strategies. As for prevention, the cause of most cancers is still poorly understood although it is clear that tobacco avoidance would prevent most lung cancers and several others. Cancer is studied at many different levels: molecular and cellular biology, pathology in patients (particularly clinical trials), and prevention and populations (epidemiology). The psychosocial problems caused to patients and their families are being increasingly recognized and subjected to systematic study. Workers in the field, therefore, range from basic scientists to epidemiologists, from hospital specialists to community support teams. Each needs to have at least some knowledge of the role the others play.


brain breast cancer cancer carcinoma cell chemotherapy gastric cancer metastasis neurosurgery oncology radiotherapy surgery tumor

Editors and affiliations

  • Maurice L. Slevin
    • 1
  • Teresa Tate
    • 1
  1. 1.Department of Medical OncologySt Bartholomew’s HospitalWest Smithfield, LondonUK

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag London 1998
  • Publisher Name Springer, London
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-76083-2
  • Online ISBN 978-1-4471-1509-0
  • Series Print ISSN 1431-3626
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology